Are CDK4/6 Inhibitors Transforming Breast Cancer Treatment?
Source: Breast Cancer Research Foundation Science News CDK4/6 inhibitors are a new class of drugs that have shown promise in the treatment of advanced ER- positive breast cancer. Cyclin dependent...